Covid-19: Govt may get Oxford shots in Jan-Feb, at 50% of MRP

India is likely to get the first lot of anti-Covid shots in late January-early February. This will be possible as India plans to give Serum Institute of India emergency use approval for the Oxford-AstraZeneca vaccine candidate soon after it gets similar approval in the UK. The government, which will make bulk purchases, has also negotiated a better price — almost half that of the likely MRP of Rs 500-600 for the two-shot vaccine.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news